• NICE recommends Sanofi’s Gaucher treatment pharmaphorum
    June 29, 2017
    England’s NHS will routinely fund Sanofi/Genzyme’s Cerdelga (eliglustat) for the rare condition Gaucher disease after a recommendation from NICE.
PharmaSources Customer Service